John Moroney

1. NRG‐GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer
   2023/12/21 by Bobbie J. Rimel, B.J. Rimel, Danielle Enserro +17 · 10 citations
   Medicine · #PARP inhibition in cancer therapy #Endometrial and Cervical Cancer Treatments #Prostate Cancer Treatment and Research
2. A General Framework for Linking Free and Forced Fluctuations via Koopmanism
   2025/06/19 by Valerio Lucarini, Lucarini, Valerio, Manuel Santos Gutierrez +5 · 2 citations
   Physics and Astronomy · #Advanced Thermodynamics and Statistical Mechanics #Model Reduction and Neural Networks #Quantum many-body systems #cond-mat.stat-mech #nlin.CD #physics.data-an